Stock 000919 JINLING PHARMACEUTICAL COMPANY LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

All News Jinling Pharmaceutical Company Limited

Equities

000919

CNE0000010W5

End-of-day quote Shenzhen S.E.
Other stock markets
 18:00:00 2024-05-30 EDT 		5-day change 1st Jan Change
6.96 CNY +0.29% Intraday chart for Jinling Pharmaceutical Company Limited -0.85% -11.56%
05-24 Jinling Pharmaceutical Company Limited Announces Final Dividend on A Shares for the Year 2023, Payable on 31 May 2024 CI
05-22 Jinling Pharmaceutical Company Limited Approves Cash Dividend for the Year 2023 CI

All News

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Jinling Pharmaceutical Company Limited Announces Final Dividend on A Shares for the Year 2023, Payable on 31 May 2024
CI
Jinling Pharmaceutical Company Limited Approves Cash Dividend for the Year 2023
CI
Jinling Pharmaceutical Company Limited Proposes Final Cash Dividend for the Year 2023
CI
Jinling Pharmaceutical Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Hefei Jinling Tianyi Smart Elderly Care Services Co., Ltd. announced that it expects to receive CNY 600 million in funding from Jinling Pharmaceutical Company Limited
CI
Jinling Pharmaceutical Company Limited Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Jinling Pharmaceutical Company Limited announced that it has received CNY 749.999998 million in funding from a group of investors
CI
Jinling Pharma in Talks to Buy Over 50% Stake in Local Hospital
MT
Jinling Pharmaceutical Company Limited agreed to acquire 43.6% stake in Nanjing Meishan Hospital Co., Ltd. from Nanjing New Industrial Investment Group Co.,Ltd. and Nanjing Zijin Investment Management Co., Ltd.
CI
Jinling Pharmaceutical Company Limited Reports Earnings Results for the Nine Months Ended September 30, 2023
CI
Jinling Pharmaceutical Company Limited Reports Earnings Results for the Half Year Ended June 30, 2023
CI
Jinling Pharma Selling 750 Million Yuan Shares to Fund New Projects
MT
Jinling Pharmaceutical Company Limited Announces 2022 Final Profit Distribution Plan to Be Implemented (A Shares), Payable on 14 July 2023
CI
Jinling Pharmaceutical Company Limited Approves Management Appointments
CI
Jinling Pharmaceutical Company Limited Approves Cash Dividend for the Year 2022
CI
Jinling Pharmaceutical Vice Chairman Resigns
MT
Jinling Pharmaceutical Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
Jinling Pharmaceutical Company Limited Proposes Final Cash Dividend for the Year 2022
CI
Jinling Pharmaceutical Company Limited announced that it expects to receive CNY 750 million in funding from Nanjing New Industrial Investment Group Co., Ltd and other investors
CI
Jinling Pharma Gets 155 Million Yuan Compensation for Office Demolition, Relocation
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 000919 Stock
  4. News Jinling Pharmaceutical Company Limited